1. Adding ezetimibe to statin treatment: is LDL-C lowering the only benefit?. (November 2012) Authors: Kostapanos, Michael S; Mikhailidis, Dimitri P; Elisaf, Moses S Journal: Future cardiology Issue: Volume 8:Number 6(2012) Page Start: 813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antihypertensive drug therapy in patients with African ancestry. (June 2014) Authors: Rizos, Christos V; Elisaf, Moses S Journal: Expert opinion on pharmacotherapy Issue: Volume 15:Number 8(2014) Page Start: 1061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antihypertensive drug therapy in patients with African ancestry. (June 2014) Authors: Rizos, Christos V; Elisaf, Moses S Journal: Expert opinion on pharmacotherapy Issue: Volume 15:Number 8(2014) Page Start: 1061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolism. (March 2011) Authors: Agouridis, Aris P; Filippatos, Theodosios D; Tsimihodimos, Vasilios; Elisaf, Moses S Journal: Expert review of cardiovascular therapy Issue: Volume 9:Number 3(2011) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of infection on lipid profile: focus on Epstein–Barr virus. (November 2010) Authors: Gazi, Irene F; Elisaf, Moses S Journal: Clinical lipidology Issue: Volume 5:Number 5(2010) Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effect of infection on lipid profile: focus on Epstein–Barr virus. (November 2010) Authors: Gazi, Irene F; Elisaf, Moses S Journal: Clinical lipidology Issue: Volume 5:Number 5(2010) Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effect of infection on lipid profile: focus on Epstein––Barr virus. (November 2010) Authors: Gazi, Irene F; Elisaf, Moses S Journal: Clinical lipidology Issue: Volume 5:Number 5(2010) Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effect of infection on lipid profile: focus on Epstein––Barr virus. (November 2010) Authors: Gazi, Irene F; Elisaf, Moses S Journal: Clinical lipidology Issue: Volume 5:Number 5(2010) Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effect of infection on lipid profile: focus on Epstein––Barr virus. (November 2010) Authors: Gazi, Irene F; Elisaf, Moses S Journal: Clinical lipidology Issue: Volume 5:Number 5(2010) Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Emerging drugs for hyperlipidaemia: an update. (December 2014) Authors: Florentin, Matilda; Kostapanos, Michael S; Kei, Anastazia; Elisaf, Moses S Journal: Expert opinion on emerging drugs Issue: Volume 19:Number 4(2014:Dec.) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗